Publicacións en colaboración con investigadores/as de Complejo Hospitalario de Toledo (10)

2020

  1. TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors

    Neuro-Oncology Advances, Vol. 2, Núm. 1

2015

  1. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients

    Journal of Neuro-Oncology, Vol. 122, Núm. 3, pp. 441-450

  2. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade

    Journal of Neuropathology and Experimental Neurology, Vol. 74, Núm. 3, pp. 241-249

2013

  1. Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors

    Acta Neuropathologica, Vol. 126, Núm. 2, pp. 277-289

2012

  1. Genetic alterations associated with progression and recurrence in meningiomas

    Journal of Neuropathology and Experimental Neurology, Vol. 71, Núm. 10, pp. 882-893

2010

  1. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas

    Neuro-Oncology, Vol. 12, Núm. 12, pp. 1278-1290

2009

  1. Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma

    Journal of Neuropathology and Experimental Neurology, Vol. 68, Núm. 3, pp. 274-285

2008

  1. Identification of survival-related genes of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma multiforme

    Cancer, Vol. 112, Núm. 7, pp. 1575-1584

2006

  1. BCR gene disruption in a pilomyxoid astrocytoma

    Neuropathology, Vol. 26, Núm. 5, pp. 442-446

  2. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling

    Molecular Cancer, Vol. 5